Hyperfine (NASDAQ: HYPR) — Perfil da empresa, notícias e dados financeiros
Hyperfine revolutionizes medical imaging with portable MRI technology, aiming to improve access and patient outcomes in healthcare.

Hyperfine
Hyperfine (NASDAQ:HYPR) focuses on revolutionizing medical imaging through its portable MRI technology. With a mission to make MRI accessible anytime, anywhere, Hyperfine is dedicated to bringing its innovative imaging solutions to a wide range of healthcare settings, from hospitals to remote clinics. Its projects include developing and deploying these portable MRI machines, which aim to drastically reduce the costs and space requirements associated with traditional MRI technology. Hyperfine's objectives are centered on improving patient outcomes through early and accessible diagnosis, expanding the reach of life-saving imaging technology to under-served communities, and continuing to innovate in the field of medical imaging to meet the diverse needs of patients and healthcare providers around the world.
Resumo
Operações
Produtos e/ou serviços de Hyperfine
- Portable MRI System designed for point-of-care imaging, streamlining diagnostics and patient management.
- AI solutions for image analysis, enhancing diagnostic accuracy and efficiency.
- Telehealth services integrating advanced imaging technology to improve remote patient care.
- Educational programs for healthcare professionals on the use of portable MRI technology.
- Mobile stroke unit integration, offering immediate brain imaging for rapid stroke diagnosis.
- Cloud-based platform for secure, accessible image storage and sharing among healthcare teams.
equipe executiva do Hyperfine
- Maria Degois-SainzCEO, President & Director
- Jonathan M. RothbergFounder & Vice Chairman
- Brett HaleChief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary
- Thomas TeisseyreChief Operating Officer
- Rafael O'HalloranVice President of Technology
- Leslie GrabGeneral Counsel
- Chip TruwitSenior Vice President of Office Strategy and Partnerships
- Edmond KnoppChief Medical Officer
- Rafael DonnaySenior Vice President of Hospital Business
- Rob FascianoChief Regulatory & Quality Officer
Últimas notícias sobre a Hyperfine
Principais indicadores financeiros
Resultados divulgados pela Hyperfine, em USD.
- Cap. de mercado
- 79,5 mi
- Receita (TTM)
- 16,5 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.4
- Dividend yield
- —
- Margem de lucro
- -210.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 13,6 mi | -37,1 mi | -35,6 mi | |
| 12,9 mi | -43,2 mi | -40,7 mi | |
| 11 mi | -48,1 mi | -44,2 mi | |
| 6,8 mi | -73,9 mi | -73,2 mi |